CARDIO-TTRANSFORM
CARDIO-TTRANSFORM
The purpose of this study is to learn more about the investigational drug, ION-682884 which may be helpful in treating Transthyretin-Mediated-Amyloid Cardiomyopathy. We are hoping to learn more about the safety and effectiveness of the study drug and learn if it can help people with Transthyretin-Mediated-Amyloid Cardiomyopathy. During this study, you will be followed by the study team for three years with 18 doctors visits throughout the three years.
Feel free to contact the KCVI clinical trials team for any information regarding this trial or upcoming clinical trials.
Phone: 503-418-1964
Email: heartresearch@ohsu.edu